Prevention and Management of Supine Hypertension in Patients With Orthostatic Hypotension
- PMID: 31524637
- DOI: 10.1097/MJT.0000000000001054
Prevention and Management of Supine Hypertension in Patients With Orthostatic Hypotension
Abstract
Background: Orthostatic hypotension (OH) is a potentially debilitating condition caused by dysfunction of the autonomic nervous system, which is essential for the physiologic response to orthostatic posture. In addition to OH, autonomic dysfunction may also be associated with the development of concurrent supine hypertension (SH).
Areas of uncertainty: This paradoxical effect speaks to the complexity of the pathogenesis of autonomic disease and greatly complicates management of these patients. Clinicians are faced with a dilemma because aggressive treatment of orthostatic intolerance can worsen supine hypertension and attempts to control supine hypertension can worsen orthostatic intolerance.
Data sources: Systematic review of the published literature.
Prevention of supine hypertension: Patients should aim to avoid known stressors, perform physical maneuvers (eg, slowly getting up from bed, sleeping with head of bed elevated), manage underlying related conditions (eg, diabetes mellitus), and exercise.
Management of supine hypertension: With failure of conservative management, patients may advance to pharmacologic therapy. It is important to understand the underlying suspected etiology of the syndrome of supine hypertension and OH (SH-OH) to select promising pharmacologic agents. This article reviews medical treatment options to work toward achieving a better quality of life for patients afflicted with this disease. Although clonidine and beta-blockers can be used to treat hypertension without causing significant hypotension, midodrine, pyridostigmine, and droxidopa may be helpful in preventing OH.
Conclusion: The etiology and severity of autonomic dysfunction vary widely between patients, suggesting a need for an individualized treatment approach. Achieving perfect blood pressure control is not a realistic goal. Rather, treatment should be aimed at improving the patient's quality of life and decreasing their risk of injury and organ damage.
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Similar articles
-
Dysautonomia: A Forgotten Condition - Part 1.Arq Bras Cardiol. 2021 Apr;116(4):814-835. doi: 10.36660/abc.20200420. Arq Bras Cardiol. 2021. PMID: 33886735 Free PMC article. English, Portuguese.
-
Diagnosing and treating neurogenic orthostatic hypotension in primary care.Postgrad Med. 2015;127(7):702-15. doi: 10.1080/00325481.2015.1050340. Epub 2015 May 27. Postgrad Med. 2015. PMID: 26012731 Review.
-
Chemical pharmacotherapy for the treatment of orthostatic hypotension.Expert Opin Pharmacother. 2019 Feb;20(2):187-199. doi: 10.1080/14656566.2018.1543404. Epub 2018 Nov 8. Expert Opin Pharmacother. 2019. PMID: 30376728 Review.
-
Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension.Curr Neurol Neurosci Rep. 2021 Mar 9;21(4):18. doi: 10.1007/s11910-021-01104-3. Curr Neurol Neurosci Rep. 2021. PMID: 33687577 Free PMC article. Review.
-
Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials.Ann Pharmacother. 2018 Dec;52(12):1182-1194. doi: 10.1177/1060028018786954. Epub 2018 Jul 4. Ann Pharmacother. 2018. PMID: 29972032
Cited by
-
Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's page series.J Thromb Thrombolysis. 2021 Oct;52(3):692-707. doi: 10.1007/s11239-021-02549-6. Epub 2021 Aug 17. J Thromb Thrombolysis. 2021. PMID: 34403043 Free PMC article. Review.
References
-
- Kanjwal K, George A, Figueredo VM, et al. Orthostatic hypotension: definition, diagnosis and management. J Cardiovasc Med (Hagerstown). 2015;16:75–81.
-
- Jordan J, Biaggioni I. Diagnosis and treatment of supine hypertension in autonomic failure patients with orthostatic hypotension. J Clin Hypertens. 2002;4:139–145.
-
- Arnold AC, Biaggioni I. Management approaches to hypertension in autonomic failure. Curr Opin Nephrol Hypertens. 2012;21:481–485.
-
- Jacob G, Shannon JR, Black B, et al. Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation. 1997;96:575–580.
-
- Ruzieh M, Dasa O, Pacenta A, et al. Droxidopa in the treatment of postural orthostatic tachycardia syndrome. Am J Ther. 2017;24:e157–e161.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials